AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10093625 — intervention group
Group type: COMPARATOR
Intervention: Epirubicin (at doses equivalent to doxorubicin)
Number of subjects: 13
Study 10093625 — intervention group
Group type: COMPARATOR
Intervention: Epirubicin (higher doses)
Number of subjects: 13
Study 10093625 — intervention group
Group type: COMPARATOR
Intervention: Epirubicin
Number of subjects: 13
Study 8063233 — intervention group
Group type: EXPERIMENTAL
Intervention: CA 125 (> 65 U/ml)
Number of subjects: 388
Study 8063233 — intervention group
Group type: EXPERIMENTAL
Intervention: CA 125 (> 35 U/ml)
Number of subjects: 388
Study 8063233 — intervention group
Group type: EXPERIMENTAL
Intervention: Transabdominal ultrasound (US)
Number of subjects: 388
Study 8063233 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of US and CA 125 (> 65 U/ml)
Number of subjects: 388
Study 2899510 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg b.d.
Number of subjects: 6
Study 2899510 — intervention group
Group type: EXPERIMENTAL
Intervention: Indenolol 60 mg o.d.
Number of subjects: 6
Study 2899510 — intervention group
Group type: COMPARATOR
Intervention: Tyramine (i.v. boluses of 1-6 mg)
Number of subjects: 6
Study 30898974 — intervention group
Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test (TSST) immediately following the encoding part of the memory task
Number of subjects: 69
Study 30898974 — intervention group
Group type: COMPARATOR
Intervention: Control version of the TSST that did not induce a stress response
Number of subjects: 69
Study 29187126 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based training program
Number of subjects: 86
Study 23299761 — intervention group
Group type: EXPERIMENTAL
Intervention: D/E only
Number of subjects: 107
Study 23299761 — intervention group
Group type: EXPERIMENTAL
Intervention: D/E plus fenofibrate
Number of subjects: 107
Study 23299761 — intervention group
Group type: EXPERIMENTAL
Intervention: D/E plus niacin
Number of subjects: 107
Study 23299761 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 107
Study 23299761 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (D/E, D/E plus fenofibrate, D/E plus niacin)
Number of subjects: 107
Study 20932669 — intervention group
Group type: EXPERIMENTAL
Intervention: Early radiotherapy (RT) with chemotherapy (fluorouracil 375 mg/m(2)/day and leucovorin 20 mg/m(2)/day) starting on Day 1 of the first chemotherapy cycle
Number of subjects: 308
Study 20932669 — intervention group
Group type: COMPARATOR
Intervention: Late radiotherapy (RT) with chemotherapy (fluorouracil 375 mg/m(2)/day and leucovorin 20 mg/m(2)/day) starting on Day 1 of the third chemotherapy cycle
Number of subjects: 308
Study 20932669 — intervention group
Group type: EXPERIMENTAL
Intervention: Early RT arm (for patients who underwent abdominoperineal resection)
Number of subjects: 308
Study 20932669 — intervention group
Group type: COMPARATOR
Intervention: Late RT arm (for patients who underwent abdominoperineal resection)
Number of subjects: 308
Study 20932669 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 308
Study 18647255 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 367
Study 18647255 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Related Quality of Life (HRQoL)
Number of subjects: 367
Study 18647255 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to General Practitioners
Number of subjects: 367
Study 18647255 — intervention group
Group type: EXPERIMENTAL
Intervention: Level of isolation
Number of subjects: 367
Study 16739703 — intervention group
Group type: EXPERIMENTAL
Intervention: Relapsing Remitting Multiple Sclerosis (RRMS)
Number of subjects: 27
Study 16739703 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary Progressive Multiple Sclerosis (SPMS)
Number of subjects: 27
Study 16739703 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 27
Study 15311098 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (increased use of antihypertensive medications)
Number of subjects: 940
Study 15311098 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-channel blockers (CCBs)
Number of subjects: 940
Study 15311098 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme (ACE) inhibitors
Number of subjects: 940
Study 15311098 — intervention group
Group type: COMPARATOR
Intervention: Diuretics
Number of subjects: 940
Study 15311098 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall BP awareness and treatment
Number of subjects: 940
Study 15311098 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatal and non-fatal cardiovascular (CV) events
Number of subjects: 940
Study 11157432 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor outcome group (bipolar disorder)
Number of subjects: 44
Study 11157432 — intervention group
Group type: COMPARATOR
Intervention: Good outcome group (bipolar disorder)
Number of subjects: 44
Study 11157432 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 44
Study 9661022 — intervention group
Group type: EXPERIMENTAL
Intervention: ZDV (200 mg every 8 h) alone for 4 days
Number of subjects: 18
Study 9661022 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritonavir (300 mg q6h) alone for 4 days
Number of subjects: 18
Study 9661022 — intervention group
Group type: EXPERIMENTAL
Intervention: ZDV with ritonavir for 4 days
Number of subjects: 18
Study 8151265 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin, 850 mg b.i.d.
Number of subjects: 18
Study 8151265 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol CR, 100 mg o.d.
Number of subjects: 18
Study 8151265 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 2575021 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta adrenergic‐blocking agents administered in the acute phase of myocardial infarction
Number of subjects: 0
Study 31168742 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on the health belief model, 4 sessions of 90 minutes each
Number of subjects: 80
Study 31168742 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on the health belief model
Number of subjects: 80
Study 31168742 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study 30648231 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese translation of the Cancer Survivor Profile for breast cancer (CSPro‐BC)
Number of subjects: 444
Study 28486729 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration group (VIB)
Number of subjects: 50
Study 28486729 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-vibration group (N-VIB)
Number of subjects: 50
Study 28486729 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 26208230 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 doses of tranexamic acid (TXA) 15 mg/kg
Number of subjects: 80
Study 26208230 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl (NSS) or placebo
Number of subjects: 80
Study 24179982 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Group (immediate implant placement and provisionalisation)
Number of subjects: 50
Study 24179982 — intervention group
Group type: COMPARATOR
Intervention: Delayed Group (immediate socket grafting followed by implant placement and provisionalisation after 4 months)
Number of subjects: 50
Study 24179982 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Group
Number of subjects: 50
Study 24179982 — intervention group
Group type: COMPARATOR
Intervention: Delayed Group
Number of subjects: 50
Study 21477541 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated tourniquet pressure
Number of subjects: 244
Study 21477541 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard tourniquet pressure)
Number of subjects: 244
Study 19567910 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 40 mg/kg/day in three doses
Number of subjects: 168
Study 19567910 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study 19567910 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 168
Study 16546635 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative antibiotics (Group Ab: 2.4 mIU of intramuscular penicillin G benzathine or 5-7 day regimen of oral clindamycin if allergic)
Number of subjects: 181
Study 16546635 — intervention group
Group type: COMPARATOR
Intervention: No postoperative antibiotics (Group non-Ab)
Number of subjects: 181
Study 16546635 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Group Ab and Group non-Ab
Number of subjects: 181
Study 16162988 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT)
Number of subjects: 60
Study 16162988 — intervention group
Group type: COMPARATOR
Intervention: Stretching protocol
Number of subjects: 60
Study 12969666 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative abdominal exercises using the Abdotrim abdominal exerciser
Number of subjects: 93
Study 12969666 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pre-operative exercises)
Number of subjects: 93
Study 10662479 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B plus G-CSF (1 mg/kg daily plus 3 to 5 micrograms/kg daily)
Number of subjects: 59
Study 10662479 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B monotherapy (1 mg/kg daily)
Number of subjects: 59
Study 10662479 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B plus G-CSF
Number of subjects: 59
Study 10662479 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B monotherapy
Number of subjects: 59
Study 7786939 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational visit and supporting material from a doctor or pharmacist
Number of subjects: 286
Study 7786939 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational visit)
Number of subjects: 286
Study 2108529 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-induced pattern-sensitive epilepsy triggers (specific spatial structured stimuli)
Number of subjects: 5
Study 2108529 — intervention group
Group type: EXPERIMENTAL
Intervention: Full neurophysiological assessment (baseline EEG recording, activation methods)
Number of subjects: 5
Study 322793 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 46
Study 322793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 31840522 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Supported Agriculture (CSA) program with 8 biweekly fresh food deliveries and cooking education
Number of subjects: 60
Study 31840522 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Supported Agriculture (CSA) program
Number of subjects: 60
Study 30369285 — intervention group
Group type: EXPERIMENTAL
Intervention: NHC intervention group (n=7)
Number of subjects: 14
Study 30369285 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=7)
Number of subjects: 14
Study 28682811 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior tibial artery
Number of subjects: 234
Study 28682811 — intervention group
Group type: COMPARATOR
Intervention: Radial artery
Number of subjects: 234
Study 28682811 — intervention group
Group type: COMPARATOR
Intervention: Dorsalis pedis artery
Number of subjects: 234
Study 26319283 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavioural therapy (delivered once a week for 10 weeks)
Number of subjects: 108
Study 26319283 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy exercise (ten sessions over a 6-week period)
Number of subjects: 108
Study 26319283 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavioural therapy
Number of subjects: 108
Study 23889915 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermocool SF(®) catheter with a porous tip (56 holes)
Number of subjects: 160
Study 23889915 — intervention group
Group type: COMPARATOR
Intervention: Thermocool(®) catheter with 6 irrigation holes
Number of subjects: 160
Study 21242484 — intervention group
Group type: EXPERIMENTAL
Intervention: Watchman Left Atrial Appendage System
Number of subjects: 1002
Study 19321009 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement plan targeting primary health care professionals, including educational sessions, feedback, audit, and implementation of clinical practice guidelines.
Number of subjects: 0
Study 19321009 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study 16949348 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba
Number of subjects: 3072
Study 16949348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3072
Study 15091224 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency pulsed electromagnetic energy (Diapulse)
Number of subjects: 37
Study 15091224 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 10695916 — intervention group
Group type: EXPERIMENTAL
Intervention: Pencil-point spinal needle (n=106)
Number of subjects: 215
Study 10695916 — intervention group
Group type: COMPARATOR
Intervention: Cutting-point spinal needle (n=109)
Number of subjects: 215
Study 10695916 — intervention group
Group type: EXPERIMENTAL
Intervention: Both needle types
Number of subjects: 215
Study 10695916 — intervention group
Group type: COMPARATOR
Intervention: Cutting-point needle
Number of subjects: 215
Study 10695916 — intervention group
Group type: EXPERIMENTAL
Intervention: Pencil-point needle
Number of subjects: 215
Study 9359660 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea and didanosine (ddI) combination treatment
Number of subjects: 0
Study 8243006 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol 320 mg I/ml
Number of subjects: 76
Study 8243006 — intervention group
Group type: COMPARATOR
Intervention: Ioxaglate 320 mg I/ml
Number of subjects: 76
Study 8243006 — intervention group
Group type: EXPERIMENTAL
Intervention: Both iodixanol and ioxaglate
Number of subjects: 76
Study 3985659 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised fenoterol
Number of subjects: 14
Study 3985659 — intervention group
Group type: COMPARATOR
Intervention: Metered aerosol
Number of subjects: 14
Study 29566740 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgotinib 50 mg
Number of subjects: 0
Study 29566740 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgotinib 100 mg
Number of subjects: 0
Study 29566740 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgotinib 200 mg
Number of subjects: 0
Study 29566740 — intervention group
Group type: COMPARATOR
Intervention: Placebo (add-on therapy)
Number of subjects: 0
Study 29566740 — intervention group
Group type: COMPARATOR
Intervention: Placebo (monotherapy)
Number of subjects: 0
Study 28153608 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent lower limb occlusion (OCC)
Number of subjects: 16
Study 28153608 — intervention group
Group type: COMPARATOR
Intervention: Control (SHAM)
Number of subjects: 16
Study 25607903 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprietary lightening product
Number of subjects: 80
Study 25607903 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin 0.05% cream
Number of subjects: 80
Study 25607903 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 80
Study 23661149 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived emotional support
Number of subjects: 123
Study 23661149 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate family contact
Number of subjects: 123
Study 23661149 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived practical support
Number of subjects: 123
Study 21507049 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted multiple interventions
Number of subjects: 1822
Study 21507049 — intervention group
Group type: COMPARATOR
Intervention: Standard fall prevention interventions
Number of subjects: 1822
Study 18032779 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (400 U/d)
Number of subjects: 1434
Study 18032779 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1434
Study 17068701 — intervention group
Group type: EXPERIMENTAL
Intervention: Crosslinked polyethylene (Duration)
Number of subjects: 127
Study 17068701 — intervention group
Group type: COMPARATOR
Intervention: Conventional polyethylene
Number of subjects: 127
Study 14523310 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric hamstring muscle contractions (MVC) at 30 degrees flexion
Number of subjects: 20
Study 14523310 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric contractions at 10, 20, 30, 40, 50, 60, 70, 80, and 90% of their three highest averaged MVC
Number of subjects: 20
Study 14523310 — intervention group
Group type: EXPERIMENTAL
Intervention: Second day perceived exertion ratings
Number of subjects: 20
Study 11470718 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified pork with high polyunsaturated fatty acids (PUFAs)
Number of subjects: 20
Study 11470718 — intervention group
Group type: COMPARATOR
Intervention: Standard pork
Number of subjects: 20
Study 9748886 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam (12 g i.v. bolus) with Dextran 40 (500 ml daily)
Number of subjects: 47
Study 9748886 — intervention group
Group type: COMPARATOR
Intervention: Placebo with Dextran 40 (500 ml daily)
Number of subjects: 47
Study 7827714 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (200 to 250 mg loading and 3 mg/min maintenance infusions)
Number of subjects: 27
Study 7827714 — intervention group
Group type: EXPERIMENTAL
Intervention: Procainamide (1 gm loading and 3 to 4 mg/min maintenance infusions)
Number of subjects: 27
Study 3421455 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium
Number of subjects: 0
Study 3421455 — intervention group
Group type: COMPARATOR
Intervention: Pethidine
Number of subjects: 0
Study 3421455 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 30772583 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated GVO plus carvedilol
Number of subjects: 121
Study 30772583 — intervention group
Group type: COMPARATOR
Intervention: Repeated GVO
Number of subjects: 121
Study 28729321 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief structured behavioural intervention
Number of subjects: 205
Study 28729321 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 205
Study 28729321 — intervention group
Group type: EXPERIMENTAL
Intervention: Population-based model
Number of subjects: 205
Study 28729321 — intervention group
Group type: COMPARATOR
Intervention: Usual care (population-based model)
Number of subjects: 205
Study 26482258 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean systolic BP ≥ 140 mmHg
Number of subjects: 1448
Study 26482258 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean diastolic BP ≥ 80 mmHg
Number of subjects: 1448
Study 26482258 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean systolic BP <120 mmHg to ≥150 mmHg
Number of subjects: 1448
Study 22752958 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified-release prednisone (5 mg)
Number of subjects: 14
Study 22752958 — intervention group
Group type: COMPARATOR
Intervention: Standard prednisolone (5 mg)
Number of subjects: 14
Study 21471141 — intervention group
Group type: EXPERIMENTAL
Intervention: C trachomatis positive
Number of subjects: 8441
Study 21471141 — intervention group
Group type: COMPARATOR
Intervention: C trachomatis negative
Number of subjects: 8441
Study 18177866 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 microg of recombinant hCG
Number of subjects: 0
Study 18177866 — intervention group
Group type: COMPARATOR
Intervention: 7,500 IU of urinary hCG
Number of subjects: 0
Study 17051589 — intervention group
Group type: EXPERIMENTAL
Intervention: ICAM1 gly241arg (heterozygotes)
Number of subjects: 563
Study 17051589 — intervention group
Group type: EXPERIMENTAL
Intervention: NOS3 glu298asp (heterozygotes)
Number of subjects: 563
Study 17051589 — intervention group
Group type: EXPERIMENTAL
Intervention: NPPA 2238T > C (heterozygotes)
Number of subjects: 563
Study 17051589 — intervention group
Group type: EXPERIMENTAL
Intervention: ADD1 gly460trp (heterozygotes)
Number of subjects: 563
Study 17051589 — intervention group
Group type: EXPERIMENTAL
Intervention: NPPA (homozygote variants)
Number of subjects: 563
Study 17051589 — intervention group
Group type: EXPERIMENTAL
Intervention: ADD1 (homozygote variants)
Number of subjects: 563
Study 17051589 — intervention group
Group type: EXPERIMENTAL
Intervention: NOS3 (smokers with 1 or 2 variant alleles)
Number of subjects: 563
Study 17051589 — intervention group
Group type: EXPERIMENTAL
Intervention: ICAM1 (smokers with 1 or 2 variant alleles)
Number of subjects: 563
Study 17051589 — intervention group
Group type: EXPERIMENTAL
Intervention: NPPA (smokers with 1 or 2 variant alleles)
Number of subjects: 563
Study 14631461 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic beverage containing Lactobacillus casei Shirota (LcS)
Number of subjects: 70
Study 14631461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 10571606 — intervention group
Group type: EXPERIMENTAL
Intervention: Prucalopride 2 mg
Number of subjects: 24
Study 10571606 — intervention group
Group type: EXPERIMENTAL
Intervention: Prucalopride 1 mg
Number of subjects: 24
Study 10571606 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 24
Study 8561535 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass at 28 degrees C
Number of subjects: 45
Study 8561535 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass at 32 degrees C
Number of subjects: 45
Study 8561535 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass at 37 degrees C
Number of subjects: 45
Study 1888787 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicitra (sodium citrate and citric acid)
Number of subjects: 86
Study 1888787 — intervention group
Group type: COMPARATOR
Intervention: Control (no Bicitra)
Number of subjects: 86
Study 1888787 — intervention group
Group type: EXPERIMENTAL
Intervention: Nausea group (those who experienced nausea)
Number of subjects: 86
Study 1888787 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-nausea group (those who were free from nausea)
Number of subjects: 86
Study 6214441 — intervention group
Group type: EXPERIMENTAL
Intervention: Zimelidine
Number of subjects: 34
Study 6214441 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 34
Study 31846558 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D HD endoscopy
Number of subjects: 30